share_log

Golden Sun Health Technology Group Limited Announces 1-for-10 Share Consolidation

Golden Sun Health Technology Group Limited Announces 1-for-10 Share Consolidation

金太陽健康科技集團有限公司宣佈以1比10的比例進行股票合併
GlobeNewswire ·  04/17 20:00

Shanghai, China, April 17, 2024 (GLOBE NEWSWIRE) -- Golden Sun Health Technology Group Limited, formerly known as Golden Sun Education Group Limited (the "Company" or "Golden Sun") (Nasdaq: GSUN), a provider of tutorial services in China, today announced that the shareholders of the Company had approved a proposed 1-for-10 share consolidation of the Company's ordinary shares (the "Share Consolidation") at an extraordinary general meeting of shareholders (the "Meeting") held on April 11, 2024, at 8th Floor, Administration Building, 390 East Tiyuhui Road, Hongkou District, Shanghai, China.

中國上海,2024年4月17日(GLOBE NEWSWIRE)——中國教程服務提供商金太陽健康科技集團有限公司(前身爲金太陽教育集團有限公司(“公司” 或 “金太陽”)(納斯達克股票代碼:GSUN)今天宣佈,公司股東已在特別股東大會上批准了對公司普通股進行1比10股合併的提議(“股份合併”)(納斯達克股票代碼:GSUN)(“會議”)於 2024 年 4 月 11 日在虹口體育匯東路 390 號行政大樓 8 樓舉行中國上海市。

At the opening of trading on April 19, 2024, the Company's class A ordinary shares will begin trading on a post-Share Consolidation basis on the Nasdaq Stock Market under the same symbol "GSUN", but under a new CUSIP number of G4013A115. The primary objective of the Share Consolidation is to enable the Company to regain compliance with Nasdaq Listing Rule 5550(a)(2) relating to the minimum bid price per share of the Company's Class A ordinary shares.

在2024年4月19日開盤交易時,該公司的A類普通股將在股票整合後在納斯達克股票市場開始交易,股票代碼相同 “GSUN”,但新的CUSIP編號爲 G4013A115。股票合併的主要目標是使公司能夠重新遵守有關公司A類普通股每股最低出價的《納斯達克上市規則》第5550(a)(2)條。

As a result of the Share Consolidation, every ten issued and outstanding ordinary shares of a par value of US$0.0005 each will be consolidated into one issued and outstanding ordinary share of a par value of US$0.005 each. No fractional shares will be issued; instead, any fractional shares that would have resulted from the Share Consolidation will be rounded up to the next whole number. The Share Consolidation affects all shareholders uniformly and will not alter any shareholder's percentage interest in the Company's outstanding ordinary shares, except for adjustments that may result from the rounding up of fractional shares.

由於股票合併,每十股面值爲0.0005美元的已發行和流通普通股將合併爲一股面值爲0.005美元的已發行和流通普通股。不會發行零碎股票;相反,股票合併產生的任何零星股票將四捨五入到下一個整數。股票合併對所有股東具有統一影響,不會改變任何股東在公司已發行普通股中的權益百分比,但部分股份四捨五入可能導致的調整除外。

About Golden Sun Health Technology Group Limited

關於金太陽健康科技集團有限公司

Established in 1997 and headquartered in Shanghai, China, Golden Sun Health Technology Group Limited, formerly known as Golden Sun Education Group Limited, is a provider of tutorial services in China with over twenty years of experience providing educational services that focus on the development of each of its student's strengths and potential, and the promotion of life-long skills and interests in learning. Golden Sun has three tutorial centers, one educational company that partners with high schools to offer language classes, and one logistics company that provides logistic and consulting services. The tutorial centers of Golden Sun focus on different groups of targeted students by offering different tutorial programs. For more information, visit the Company's website at ir.jtyjyjt.com.

金太陽健康科技集團有限公司(前身爲金太陽教育集團有限公司)成立於1997年,總部位於中國上海,是中國補習服務提供商,在提供教育服務方面擁有二十多年的經驗,這些教育服務側重於發展每個學生的優勢和潛力,並促進終身學習技能和興趣。Golden Sun有三個補習中心,一家與高中合作提供語言課程的教育公司,以及一家提供物流和諮詢服務的物流公司。Golden Sun的補習中心通過提供不同的補習計劃,專注於不同的目標學生群體。欲了解更多信息,請訪問該公司的網站 ir.jtyjyjt.com

Forward-Looking Statements

前瞻性陳述

Certain statements in this announcement are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company's current expectations and projections about future events that the Company believes may affect its financial condition, results of operations, business strategy and financial needs. Investors can identify these forward-looking statements by words or phrases such as "approximates," "assesses," "believes," "hopes," "expects," "anticipates," "estimates," "projects," "intends," "plans," "will," "would," "should," "could," "may" or similar expressions. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company's annual report and other filings with the U.S. Securities and Exchange Commission.

本公告中的某些陳述是前瞻性陳述。這些前瞻性陳述涉及已知和未知的風險和不確定性,基於公司當前對未來事件的預期和預測,公司認爲這些預期和預測可能會影響其財務狀況、經營業績、業務戰略和財務需求。投資者可以通過諸如 “近似”、“評估”、“相信”、“希望”、“期望”、“預期”、“預期”、“估計”、“項目”、“打算”、“計劃”、“將”、“將”、“應該”、“可能”、“可能” 或類似的表述來識別這些前瞻性陳述。除非法律要求,否則公司沒有義務公開更新或修改任何前瞻性陳述以反映隨後發生的事件或情況或預期的變化。儘管公司認爲這些前瞻性陳述中表達的預期是合理的,但它無法向您保證此類預期是正確的。公司提醒投資者,實際業績可能與預期業績存在重大差異,並鼓勵投資者在公司的年度報告和向美國證券交易委員會提交的其他文件中審查可能影響其未來業績的其他因素。

For more information, please contact:

欲了解更多信息,請聯繫:

Golden Sun Health Technology Group Limited
Investor Relations Department
Email: ir@cngsun.com

金太陽健康科技集團有限公司
投資者關係部
電子郵件: ir@cngsun.com

Ascent Investor Relations LLC
Tina Xiao
President
Phone: +1 646-932-7242
Email: investors@ascent-ir.com

Ascent 投資者關係有限責任公司
蒂娜肖
主席
電話:+1 646-932-7242
電子郵件: investors@ascent-ir.com


譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論